🔗 Share this article

Chancellor Reeves has revealed she is planning "targeted measures to deal with household expense issues" in the upcoming Budget.

During an interview with media outlets, she emphasized that curbing price rises is a collective task of both the administration and the central bank.

The UK's price growth is projected to be the highest among the G7 advanced economies this calendar year and the following year.

Possible Energy Bill Measures

Sources suggest the administration could intervene to lower energy bills, such as by cutting the current 5% rate of VAT charged on energy supplies.

A further option is to cut some of the policy costs currently added to bills.

Budgetary Constraints and Expert Predictions

The administration will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such measures.

The expectation from most economists is that the Chancellor will have to declare tax rises or spending cuts in order to meet her self-imposed debt limits.

Previously on the same day, analysis indicated there was a twenty-two billion pound shortfall for the Treasury chief to address, which is at the more modest range of expectations.

"There's a joint responsibility between the Bank of England and the government to bear down further on some of the causes of price increases," the Chancellor told reporters in the US capital, at the annual meetings of the IMF and World Bank.

Tax Commitments and International Concerns

While much of the focus has been on expected tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her commitment to election pledges not to increase tax levels on earnings tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with rising geopolitical and commercial tensions for the Budget revenue measures, probably to be targeted on those "wealthiest."

Global Trade Disputes

Commenting on apprehensions about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests invariably come first."

Recent declaration by China to tighten export controls on critical minerals and other resources that are essential for high-technology production led American leader the US President to propose an extra 100% tariff on imports from the Asian country, increasing the prospect of an all-out trade war between the two economic giants.

The American finance chief labeled China's move "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to participate in its battle with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the action was "bad for the international commerce and creates additional challenges."

"I believe there are sectors where we must confront China, but there are also valuable opportunities to sell into China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."

The Treasury chief also affirmed she was working with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

Reeves also acknowledged that the price the National Health Service pays for drugs could increase as a consequence of current negotiations with the US government and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the world's largest pharmaceutical manufacturers have said recently that they are either delaying or abandoning investments in the United Kingdom, with some attributing the low prices they are receiving.

Recently, the government science advisor said the price the health service spends on drugs would have to go up to prevent businesses and drug research funding leaving the United Kingdom.

Reeves informed the BBC: "It has been observed because of the payment system, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"Our aim is to make sure that people receiving care from the NHS are can obtain the best essential drugs in the globe. And so we are examining this situation, and... seeking to attract increased investment into Britain."